Botalaya® Cordyceps Mycelia Powder is produced from Hirsutella sinensis, confirmed by the Mycological Society of China as the sole anamorph of Ophiocordyceps sinensis and listed in the Chinese Pharmacopoeia since 2010 — distinct from Cordyceps militaris, C. cicadae, C. liangshanensis and C. pruinosa. 

The proprietary strain was identified by the Institute of Microbiology, Chinese Academy of Sciences and granted an invention patent. Submerged liquid fermentation delivers high-purity mycelia with genetic material identical to wild Cordyceps sinensis, ensuring purity of efficacy and stability of quality while removing dependence on wild harvest.

Pharmacopoeia-aligned provenance is the headline: this is the true Cordyceps anamorph, not a substitute species — a provenance claim most competing materials cannot support. Backed by a proprietary, patented, CAS-identified strain, it integrates five efficacy directions in one ingredient, linked by one mechanistic logic: fatigue relief, immune vitality plus antioxidation, lung and kidney tissue protection, and gut microbiome regulation.